Sam North
Education
Royal Australian Navy - Electronic and Communications Advanced Diploma (TAFE).
Written For
Releaf, Fast Buds, MSNL, Paradise Seeds, Cookies Seeds, Premium Cultivars
With a background in cannabis journalism - writing for Fast Buds, Paradise Seeds, Cookies Seeds Co., MSNL, and now Releaf, Sam is an experienced cannabis expert who understands how to communicate complex ideas clearly. Collaborating with clients throughout the global cannabis industry, he has cemented himself as a leading voice within both the recreational and medicinal sectors. Whether it’s researching, writing, editing, or consulting, Sam has a commitment to accuracy and quality that clients and audiences connect to. Based between Asia, Australia, and Europe, Sam is passionate about educating and enlightening people on all aspects of cannabis. By translating scientific data into easily understandable language, he strives to bridge the gap between the medical and recreational cannabis communities. Sam believes that with the proper education, correct understanding, and honest information, everyone can benefit from the natural healing power of cannabis.
Releaf articles
A break-down of Releaf's prescription process
Here at Releaf, we have taken what some private medical cannabis clinics make into a bureaucratic maze and turned it into a smooth, efficient process that gets the vast majority of new eligible patients from eligibility check to prescription delivery in just five to seven working days.
How Releaf’s approach to UK medical cannabis branding sets a new standard
Releaf clinicians can prescribe from a carefully curated range of medical cannabis flower and medical cannabis oil products. While Releaf does not have control over the branding of a portion of the medicines we source from international medical cannabis suppliers, we have worked tirelessly to make sure that our branding, packaging, and external product selection aligns with UK medical standards.
How to refer a friend to Releaf
With medical cannabis finally becoming a mainstream talking point throughout both the UK public and Parliament (the most recent debate happened just last month), the weight of a century’s worth of stigma and misinformation is slowly beginning to lift.